Introduction Over the years, advances in the drug/therapeutic development process have led the pharmaceutical industry to gradually transform from a single-drug treatment of all models to more personalized treatment methods.
New York, November 11, 2021 (GLOBE NEWSWIRE) - Reportlinker.com announced the release of the report "The Global Pharmaceutical Vial Market-By Types of Manufacturing Materials Used, Sterilization Status, and Distribution in Key Regions-Industry Trends and Global Forecasts for 2021- 2030"-https://www.reportlinker.com/p06183521/?utm_source=GNW The increasing complexity of modern pharmacological interventions, such as monoclonal antibodies, cell and gene therapies, further encourage drug developers to develop or determine specific Filling/finishing and packaging alternatives for specific needs of such new products. Drug packaging plays a vital role in maintaining the characteristics, quality, and integrity of packaged drugs due to direct contact with drug/therapeutic formulations. Although there are various types of primary packaging containers on the market, including ampoules, cartridges, and syringes, which can be used for various types of pharmaceutical preparations, it has been observed that vials are the first choice for drug developers because they provide high container seal integrity . Despite being the most popular packaging system, traditional vials often face certain challenges, including the possibility of breakage under extreme conditions, lack of relevant information (serial or batch number) on the packaging, and the possibility of delamination. Therefore, some medicine bottle manufacturers are exploring new technologies to overcome the above-mentioned challenges associated with traditional medicine bottles in order to create better packaging solutions. Some examples of advances in this field include the use of serialization technology (to avoid drug counterfeiting), the development of multiple coating materials (to prevent delamination and pH imbalance), and the use of smart drug delivery technology (to improve patient compliance). In addition, pre-sterilized/ready-to-use (RTU) medicine bottles have become a promising alternative to traditional medicine bottles, adding important value to simplifying the drug filling/completion operation. It is worth noting that these innovations have greatly helped optimize costs, simplify the filling process and speed up production time. In addition, it enables pharmaceutical companies to overcome regulatory challenges and establish a sustainable competitive advantage in the market. In addition, due to the unprecedented outbreak of the COVID-19 pandemic, the demand for parenteral preparations has increased significantly, thus providing profitable opportunities for pharmaceutical companies engaged in the development of safe and high-quality vials. In the future, high demand for parenteral preparations and increased vaccination activities may drive the growth of the drug bottle market. Scope of the report "Global Medicine Bottle Market-Distribution by the type of manufacturing material used (glass and plastic), sterilization state (pre-sterilized and non-sterilized), and major regions (North America, Europe, Asia Pacific, Latin America, Middle East) As well as North Africa and other parts of the world)-2021-2030 Industry Trends and Global Forecasts" report conducted extensive research on the current market pattern and future potential of medicine bottles in the next ten years. The study provides an in-depth analysis of the key drivers and trends related to the field. Among other elements, the report also includes: A detailed assessment of the current market pattern of medicine bottles, including the types of manufacturing materials used for containers (glass and plastic), and the types of manufacturing materials used for bottle caps (rubber, plastic, and metal) Information), vial volume (less than 50ml, 50ml to 100ml and greater than 100ml), vial cap type (screw cap, crimp cap and snap cap), sterilization status (pre-sterilized and non-sterilized) ), types of products (untreated and processed), compatible drug categories (biological agents and small molecules), and types of stored formulations (liquid, powder, and solid). In addition, this chapter also analyzes the pharmaceutical bottle manufacturers based on various parameters, including the year of establishment, company size, headquarters location, and major players (in terms of product volume). Competitive analysis of medicine bottle manufacturers is divided into four categories, namely small (1-50 employees), medium-sized companies (51-500 employees), large (501-1,000 employees), and very large companies (more than 1,000 employees) Staff) ). In the peer group, companies are ranked according to various relevant parameters, such as supplier strength (based on the manufacturer’s experience/professional knowledge) and key product specifications (type of manufacturing materials used, type of caps, sterilization status, products, compatibility Types of medicines and types of formulas stored). The well-known companies engaged in the development of medicine bottles in North America, Europe and the Asia-Pacific region are introduced in detail. Each profile contains a brief overview of the company, detailed information (if any) related to its financial situation, product portfolio, recent developments, and smart future prospects. Analysis of partnerships signed by stakeholders involved in this field from 2015 to 2021 (to September), covering acquisitions, product/technology integration agreements, supply agreements, asset acquisitions, distribution agreements, product/technology development agreements, Product/technology license agreements and other related agreements. In addition, cooperation activities in this field have been analyzed according to various parameters, such as the year of cooperation, the types of manufacturing materials involved, the disinfection status, the types of partners, and the regional distribution of cooperation. Discuss in detail the key trends that may have an impact on the future adoption of innovative primary therapies (such as the emergence of personalized/targeted therapies, the shift to more flexible packaging, the rise of modular manufacturing facilities, and the advancement of robotic packaging solutions) packaging systems. It also has a Harvey ball analysis that highlights the relative impact of each trend on the entire pharmaceutical packaging industry. According to various relevant parameters (such as the type of manufacturing materials used, sterilization status, and region), an in-depth analysis of the current and future demand for medicine bottles during the period 2021-2030 is carried out. Case studies of the use of robotic machinery in pharmaceutical manufacturing and filling/finishing operations highlight the advantages of using automation/automation technology in such processes. In addition, it also provides an overview of the industry players that provide such equipment for the aseptic processing of pharmaceuticals. A case study of currently available pre-sterilized/RTU vials. In addition, it provides information about the various sterilization technologies used for primary packaging materials and the advantages of the RTU container closure system. One of the main goals of the report is to estimate the size of the existing market and identify potential growth opportunities for medicine bottles in the next ten years. Based on several parameters such as target consumer groups, adoption rates in specific regions, and expected prices of these products, we have provided a wise estimate of the likely evolution of the market during the period 2021-2030. The report provides sales forecasts for the entire medicine bottle market, where current and upcoming opportunities are divided into [A] the types of manufacturing materials used (glass and plastic), [B] sterilization status (pre-sterilized and non-sterilized) And [C] major regions (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and the rest of the world). In order to consider future uncertainties and add robustness to our model, we provide three market forecast scenarios, namely conservative, basic and optimistic scenarios, which represent different trajectories of industry growth. The views and insights presented in this research were influenced by discussions with multiple stakeholders in the field. This report contains detailed interview records with: Julien Marechal (Director of Business Development and Technology for Aseptic Technology) Konstantin Kazarian (Former PYRAMID Laboratory Business Development Project Manager) Lawrence Ganti (President of SiO2 Materials Science) Research Methods Provided in this report Data is collected through secondary and primary research. For all our projects, we will conduct interviews/surveys with experts in the field (academia, industry, and other associations) to solicit their opinions on emerging trends in the market. This mainly helps us to draw our own views on the market development in different regions and market segments. Where possible, the accuracy of the available data has been checked from multiple sources. Secondary sources of information include: Annual report, investor introduction, SEC documents, industry database, press releases on the company’s website, government policy documents, industry analysts’ opinions. All actual data comes from public information forums and sources and analysis of major research discussions. Unless otherwise stated, all financial data mentioned in this report are in U.S. dollars. The key question to answer: Who are the main players in the manufacturing of pharmaceutical vials? What is the relative competitiveness of different medicine bottle manufacturers? What types of partnership models are commonly used by industry stakeholders in this industry? What is the current global demand for medicine bottles? What are the emerging trends related to pharmaceutical primary packaging? What factors may affect the growth of the medicine bottle market? How might current and future opportunities be distributed among key market segments? Chapter Outline Chapter 2 is an executive summary of the key insights gained in our report. It provides a high-level view of the current state of the drug bottle market and its possible evolution in the short, medium and long term. Chapter 3 provides an overview of traditional medicine packaging and different types of packaging systems. In addition, this chapter also discusses in detail the medicine bottle, its manufacturing materials and the different types of bottle caps available. In addition, it briefly discussed the latest innovations in the field. Chapter 4 provides a comprehensive review of the current market landscape of medicine bottles, including information about the types of manufacturing materials used for containers (glass and plastic), the types of manufacturing materials used for bottle caps (rubber, plastic, and metal), and the volume of medicine bottles ( Less than 50ml, 50ml to 100ml and greater than 100ml), cap type (screw cap, crimp cap and snap cap), sterilization state (unsterilized and sterilized), product type (untreated and Processed), compatible drug categories (biological agents and small molecules), and stored formulation types (liquid, powder, and solid). In addition, this chapter also includes analysis related to medicine bottle manufacturers, based on various parameters, year of establishment, company size, headquarters location, and major players (in terms of product volume). Chapter 5 details the competitiveness analysis of medicine bottle manufacturers, which are divided into four categories, namely, small-sized (1-50 employees), medium-sized companies (51-500 employees), large-scale (501-1,000 employees), and super companies. Large companies (more than 1,000 employees). In the peer group, companies are ranked according to various relevant parameters, such as supplier strength (based on the manufacturer’s experience/professional knowledge) and key product specifications (type of manufacturing materials used, type of caps, sterilization status, products, compatibility Types of medicines and types of formulas stored). Chapter 6 details the well-known companies that develop medicine bottles in North America. Each company profile contains a brief overview of the company, detailed information (if any) related to its finances, product portfolio, recent developments, and smart future prospects. Chapter 7 details the well-known companies that develop medicine bottles in Europe. Each company profile contains a brief overview of the company, detailed information (if any) related to its finances, product portfolio, recent developments, and smart future prospects. Chapter 8 details the well-known companies that develop medicine bottles in the Asia-Pacific region. Each company profile contains a brief overview of the company, detailed information (if any) related to its finances, product portfolio, recent developments, and smart future prospects. Chapter 9 discusses and analyzes in detail the various cooperation and partnerships reached among stakeholders in this field from 2015 to 2021 (to September). In addition, cooperation activities in this field have been analyzed based on various parameters, such as the year of cooperation, the type of cooperation mode (acquisition, product/technology integration agreement, supply agreement, asset acquisition, distribution agreement, product/technology development agreement, product/technology licensing Agreement and others), the types of manufacturing materials involved, the sterilization status, the types of partners, and the regional distribution of cooperation. Chapter 10 discusses emerging trends in the entire pharmaceutical manufacturing and filling industry. Specifically, it addresses the growing demand for personalized treatments, shifts to more flexible packaging, develops modular facilities, upgrades packaging components to improve drug safety, increases partner activities, and increasingly adopts smart packaging solution. Chapter 11 outlines the current and future demand for medicine bottles in the contemporary market. In order to estimate the above demand, we considered the current supply of medicine bottles and estimated the proportion of them that may be supplied to the pharmaceutical industry before 2030. Then we divide the total demand into many related parameters, including manufacturing type materials (glass and plastic), sterilization status (pre-sterilized and non-sterilized), and geographic region (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America) And the rest of the world). Chapter 12 provides a comprehensive market forecast analysis based on multiple parameters, such as current demand for medicine bottles, possible adoption rates, and estimated prices of components, highlighting the future potential of the market by 2030. We distinguish between current and upcoming regions based on [A] the type of manufacturing materials used (glass and plastic), [B] sterilization status (pre-sterilized and non-sterilized), and [C] major regions (North America, Europe, Asia Pacific) Opportunities, the Middle East and North Africa, Latin America and the rest of the world). It is worth mentioning that we adopted a bottom-up approach in this analysis, using relevant data points and reliable input from the main research to support our claims. Chapter 13 details the role of robots in the pharmaceutical and filling/finishing processes, focusing on their advantages and functions. It provides a list of various types of pharmaceutical robots, as well as detailed information about their respective manufacturers and applications. In addition, this chapter also introduces a profile of the participants who provide robotic equipment for pharmaceutical manufacturing and filling/finishing operations, as well as information about the key specifications of their respective machines. Chapter 14 provides insights into currently available pre-sterilization/RTU vials, focusing on the drug packaging and filling process, as well as various restrictions related to the container closure systems currently in use. In addition, it discusses in detail the different sterilization technologies used for primary packaging materials and the advantages of RTU containers and closure systems. Chapter 15 summarizes the entire report. In this chapter, we provide a list of key points of the report, and express our independent opinions on the research and analysis described in the previous chapters. Chapter 16 collects interview transcripts of discussions with key stakeholders in the market. In this chapter, we detailed the interviews with Julien Marechal (Director of Aseptic Technology Business Development and Technology) and Konstantin Kazarian (Former PYRAMID Lab Business Development Project Manager). Chapter 17 is an appendix that provides tabular data and figures for all figures provided in the report. Chapter 18 is an appendix, which contains a list of companies and organizations mentioned in the report. Read the full report: https://www.reportlinker.com/p06183521/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so that you can get all the market research you need instantly in one place. __________________________ Each company profile contains a brief overview of the company, detailed information related to its finances (if any), product portfolio, recent developments, and smart future prospects. Chapter 8 details the well-known companies that develop medicine bottles in the Asia-Pacific region. Each company profile contains a brief overview of the company, detailed information (if any) related to its finances, product portfolio, recent developments, and smart future prospects. Chapter 9 discusses and analyzes in detail the various cooperation and partnerships reached among stakeholders in this field from 2015 to 2021 (to September). In addition, cooperation activities in this field have been analyzed based on various parameters, such as the year of cooperation, the type of cooperation mode (acquisition, product/technology integration agreement, supply agreement, asset acquisition, distribution agreement, product/technology development agreement, product/technology License agreement and others), types of manufacturing materials involved, sterilization status, types of partners, and regional distribution of cooperation. Chapter 10 discusses emerging trends in the entire pharmaceutical manufacturing and filling industry. Specifically, it addresses the growing demand for personalized treatments, shifts to more flexible packaging, develops modular facilities, upgrades packaging components to improve drug safety, increases partner activities, and increasingly adopts smart packaging solution. Chapter 11 outlines the current and future demand for medicine bottles in the contemporary market. In order to estimate the above demand, we considered the current supply of medicine bottles and estimated the proportion of them that may be supplied to the pharmaceutical industry before 2030. Then we divide the total demand into many related parameters, including manufacturing type materials (glass and plastic), sterilization status (pre-sterilized and non-sterilized), and geographic region (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America) And the rest of the world). Chapter 12 provides a comprehensive market forecast analysis that highlights the future potential of the market by 2030 based on multiple parameters (such as current demand for medicine bottles, possible adoption rates, and estimated prices of components). We have divided the current and upcoming regions according to [A] the type of manufacturing materials used (glass and plastic), [B] sterilization status (pre-sterilized and non-sterilized), and [C] major regions (North America, Europe, Asia Pacific) Opportunities, the Middle East and North Africa, Latin America and the rest of the world). It is worth mentioning that we adopted a bottom-up approach in this analysis, using relevant data points and credible input from the main research to support our claims. Chapter 13 details the role of robots in the pharmaceutical and filling/finishing processes, focusing on their advantages and functions. It provides a list of various types of pharmaceutical robots, as well as detailed information about their respective manufacturers and applications. In addition, this chapter also introduces a profile of the participants who provide robotic equipment for pharmaceutical manufacturing and filling/finishing operations, as well as information about the key specifications of their respective machines. Chapter 14 provides insights into currently available pre-sterilization/RTU vials, focusing on the drug packaging and filling process, as well as various restrictions related to the container closure systems currently in use. In addition, it discusses in detail the different sterilization technologies used for primary packaging materials and the advantages of RTU containers and closure systems. Chapter 15 summarizes the entire report. In this chapter, we provide a list of key points of the report, and express our independent opinions on the research and analysis described in the previous chapters. Chapter 16 collects interview transcripts of discussions with key stakeholders in the market. In this chapter, we detailed the interviews with Julien Marechal (Director of Aseptic Technology Business Development and Technology) and Konstantin Kazarian (Former PYRAMID Lab Business Development Project Manager). Chapter 17 is an appendix that provides tabular data and figures for all figures provided in the report. Chapter 18 is an appendix, which contains a list of companies and organizations mentioned in the report. Read the full report: https://www.reportlinker.com/p06183521/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so that you can get all the market research you need instantly in one place. __________________________ Each company profile contains a brief overview of the company, detailed information related to its finances (if any), product portfolio, recent developments, and smart future prospects. Chapter 8 details the well-known companies that develop medicine bottles in the Asia-Pacific region. Each company profile contains a brief overview of the company, detailed information (if any) related to its finances, product portfolio, recent developments, and smart future prospects. Chapter 9 discusses and analyzes in detail the various cooperation and partnerships reached among stakeholders in this field from 2015 to 2021 (to September). In addition, cooperation activities in this field have been analyzed based on various parameters, such as the year of cooperation, the type of cooperation mode (acquisition, product/technology integration agreement, supply agreement, asset acquisition, distribution agreement, product/technology development agreement, product/technology License agreement and others), types of manufacturing materials involved, sterilization status, types of partners, and regional distribution of cooperation. Chapter 10 discusses emerging trends in the entire pharmaceutical manufacturing and filling industry. Specifically, it addresses the growing demand for personalized treatments, shifts to more flexible packaging, develops modular facilities, upgrades packaging components to improve drug safety, increases partner activities, and increasingly adopts smart packaging solution. Chapter 11 outlines the current and future demand for medicine bottles in the contemporary market. In order to estimate the above demand, we considered the current supply of medicine bottles and estimated the proportion of them that may be supplied to the pharmaceutical industry before 2030. Then we divide the total demand into many related parameters, including manufacturing type materials (glass and plastic), sterilization status (pre-sterilized and non-sterilized), and geographic region (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America) And the rest of the world). Chapter 12 provides a comprehensive market forecast analysis that highlights the future potential of the market by 2030 based on multiple parameters (such as current demand for medicine bottles, possible adoption rates, and estimated prices of components). We have divided the current and upcoming regions according to [A] the type of manufacturing materials used (glass and plastic), [B] sterilization status (pre-sterilized and non-sterilized), and [C] major regions (North America, Europe, Asia Pacific) Opportunities, the Middle East and North Africa, Latin America and the rest of the world). It is worth mentioning that we adopted a bottom-up approach in this analysis, using relevant data points and credible input from the main research to support our claims. Chapter 13 details the role of robots in the pharmaceutical and filling/finishing processes, focusing on their advantages and functions. It provides a list of various types of pharmaceutical robots, as well as detailed information about their respective manufacturers and applications. In addition, this chapter also introduces a profile of the participants who provide robotic equipment for pharmaceutical manufacturing and filling/finishing operations, as well as information about the key specifications of their respective machines. Chapter 14 provides insights into currently available pre-sterilization/RTU vials, focusing on the drug packaging and filling process, as well as the various limitations associated with the container closure systems currently in use. In addition, it discusses in detail the different sterilization techniques used for primary packaging materials and the advantages of RTU containers and closure systems. Chapter 15 summarizes the entire report. In this chapter, we provide a list of key points of the report, and express our independent opinions on the research and analysis described in the previous chapters. Chapter 16 collects interview transcripts of discussions with key stakeholders in the market. In this chapter, we detailed the interviews with Julien Marechal (Director of Aseptic Technology Business Development and Technology) and Konstantin Kazarian (Former PYRAMID Lab Business Development Project Manager). Chapter 17 is an appendix that provides tabular data and figures for all figures provided in the report. Chapter 18 is an appendix, which contains a list of companies and organizations mentioned in the report. Read the full report: https://www.reportlinker.com/p06183521/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so that you can get all the market research you need instantly in one place. __________________________
(Bloomberg) - According to Resta Energy, soaring oil and gas prices are spurring output from West Texas to the upper reaches of the Great Plains, which may increase production to the lowest level since the beginning of the pandemic. Most articles from Bloomberg have Amazon sued for drivers rushing to deliver the new Hong Kong Museum trying to please the art world and Beijing why Hong Kong is building a parking space-sized apartment Biden plans to fund new bridges that locals may build
Deere & Co. and the American Federation of Automobile Workers reached a third provisional agreement on a contract to end the strike of agricultural and construction equipment manufacturers that began on October 14.
Kroger has avoided Florida for more than three decades, leaving the rapidly growing market to others. But now it has aggressively entered the Sunshine State this year and believes it can compete with big companies without opening any stores.
(Bloomberg)-Apple agreed to pay $29.9 million to employees in its stores who were forced to undergo security bag checks after shifts or when they were off work during shifts. A federal judge approved the settlement on Friday, which was reached after eight years of legal battles. Apple Store employees filed a class action lawsuit in 2013, claiming that the company violated California law and violated California law because they did not pay them. ch
According to several market participants, Chinese coal traders are selling goods at a loss or trying to delay imports after Beijing’s market intervention caused prices to fall by 50% and unprofitable supplies. After the government ordered top miners to lower prices to established targets and immediately increase production to curb prices that have almost quadrupled this year, domestic thermal coal futures have fallen by half in the past three weeks. Three Chinese coal traders said that with the free fall in prices, importers tried to quickly sell the coal shipments they booked in October, when prices were at record levels, with losses between 40 and 100 US dollars per ton.
Yahoo Finance’s Alexandra Canal broke the latest developments in the streaming war.
General Motors accounts for approximately 10% of the electric vehicle (EV) market, while Tesla accounts for approximately 63%. Despite this, Barra said that she believes that General Motors is the leader of the United States and China's second place.
Nvidia CEO Jensen Huang said that artificial intelligence is the most powerful technology in the world, and the company is using it to create some impressive new products.
Historically, the cure for high oil prices has always been high oil prices. Even if gasoline and diesel prices increase, vehicle traffic mostly maintains an upward trend. Oil and natural gas prices have been rising and are beginning to ripple through the entire economy.
Rivian, another electric startup, roared into the market with no sales but a higher valuation than Ford and General Motors.
Selling electricity directly to retail customers will be a major expansion of the electric car manufacturer's ambitions.
The Chinese version of Black Friday witnessed Alibaba’s sales last year, although year-on-year sales growth does appear to be slowing.
(Bloomberg)-The trading department has just begun its second iconic year, when senior executives began defecting to companies such as Bank of America, Citigroup, and Millennium Management. By this fall, many of the team's heaviest hitters had left. Most of the readers from Bloomberg read why apartments built in Hong Kong are as big as parking spaces. Farmers bear the “post-apocalyptic” food crisis. Greece’s popular islands are crowded-are plastic prisons worth a second chance? Setting is not some s
An industry veteran found hope in both traditional and alternative energy names. Why does he like Diamondback Energy, Antero Resources, EQT, Cottera Energy, PDC, EOG, Enphase, Enviva, etc.
There are not many semiconductor stocks that seem to be cheap at the moment, but Axcelis Technologies is indeed cheap despite rising prices.
Business leaders in organizations large and small face a common challenge: they cannot find enough employees to fill all their vacant positions. Although there are several factors that contribute to the shortage of workers (and there must be COVID-19 issues among them), many employers ignore their treatment of job applicants, making the situation worse. According to a 2020 report by the Talent Committee, less than one-third of job seekers said their job search experience was great, and 73% of job seekers said the job search process is one of the most stressful things in life.
Veteran reporter Brian Williams said that after working at NBC for nearly three years, he will leave his job at MSNBC at the end of this year-but this is not a retirement announcement. Williams, 62, said he will spend a few months with his family after his contract expires in December. For some Americans, Williams’ career strategy may sound familiar—even desirable.
The pharmaceutical giant Johnson & Johnson will split into two companies in the next two years, one is a consumer brand and the other is a pharmaceutical brand.
More than a year after Kraft Heinz announced the sale of its domestic natural cheese business to Lactalis, the US Department of Justice requested the divestiture of the Athenos and Polly-O brands. The U.S. Department of Justice's Antitrust Division filed a civil antitrust lawsuit in the U.S. District Court for the District of Columbia on Wednesday to block the proposed transaction.
Olaplex CEO JuE Wong joined the Yahoo Finance Live to discuss the growth and expansion of her hair care brand in the beauty and hair care market.